Immunology/Inflammation
Read More about this categoryShow Less
The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.
Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].
BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].
Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.
Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].
References
[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.
[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.
[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.
[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.
[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.
[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.
[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.
[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.
Research Areas
- 5-Lipoxygenase(17)
- Apoptosis(753)
- Cyclic GMP-AMP Synthase(6)
- TLR(124)
- Papain(1)
- PGDS(1)
- PGE synthase(26)
- SIKs(12)
- IκB/IKK(68)
- AP-1(14)
- KEAP1-Nrf2(58)
- NOD1(1)
- NF-κB(312)
- Interleukin Related(303)
- 15-lipoxygenase(2)
- Others(10)
- Aryl Hydrocarbon Receptor(42)
- CD73(17)
- Complement System(74)
- Galectin(13)
- IFNAR(60)
- NO Synthase(95)
- NOD-like Receptor (NLR)(68)
- STING(120)
- Reactive Oxygen Species(522)
- FKBP(16)
- eNOS(4)
- iNOS(29)
- nNOS(20)
- Glutathione(54)
- Adaptive Immunity(210)
- Allergy(118)
- Arthritis(34)
- Autoimmunity(181)
- Gastric Disease(94)
- Immunosuppressants(38)
- Immunotherapeutics(4)
- Innate Immunity(566)
- Pulmonary Diseases(109)
- Reactive Nitrogen Species(50)
- Specialized Pro-Resolving Mediators(49)
- Reactive Sulfur Species(28)
- BCL6(8)
- CD20(14)
- CD28(4)
- PSMA(15)
- FAP(24)
- Nuclear Factor of activated T Cells (NFAT)(2)
- Glycoprotein VI(2)
- Tim3(4)
- Hapten(1)
- Nectin-4(3)
- DOCK(4)
- MHC(10)
- Transmembrane Glycoprotein(31)
- TREM receptor(11)
- Inflammation or Immune System Disease(2)
- Musculoskeletal and Skin Disease(1)
- Fc Receptor (FcR)(12)
- IKZF Family(5)
- C-type Lectin-like Receptors (CTLRs)(9)
- Asialoglycoprotein Receptor (ASGPR)(3)
- Human leukocyte immunoglobulin (Ig)-like receptors (LILR)(1)
Products Related to Immunology/Inflammation(4623)
- GC79383Anti-Mouse IL-17A Antibody (BZN035)Purity: >97.50%
Anti-Mouse IL-17A Antibody (BZN035) is an antibody targeting mouse IL-17A, which binds to and neutralizes the activity of mouse IL-17A.
- GC79385Anti-Mouse IL-4Rα Antibody (REGN1103)Purity: >99.50%
Anti-Mouse IL-4Rα Antibody (REGN1103) is a mouse homologous antibody targeting IL-4Rα, as well as an inhibitor of IL-4 signaling.
- GC79386Anti-Mouse IL-2 Antibody (JES6-5H4)Purity: >98.50%
Anti-Mouse IL-2 Antibody (JES6-5H4) reacts with mouse IL-2 that can neutralize IL-2 in vivo.
- GC79394IL4RPep-1 acetatePurity: >98.50%
IL4RPep-1 acetate is an interleukin-4 receptor ( IL-4R ) binding agent.
- GC79396Anti-CD3 Antibody (UCHT-1)Purity: >97.00%
Anti-CD3 Antibody (UCHT-1) is an antibody targeting CD3.
- GC793972'2'-cGAMP disodiumPurity: >99.50%
2'2'-cGAMP disodium, a synthetic CDN, binds STING in the immune response, inducing IFN-β. 2'2'-cGAMP disodium binds weaker binding to STING than 2'3'-cGAMP but stronger than other CDNs [1] .
- GC79398ElfritatugCAS: 3058391-18-4Purity: >98.50%
Elfritatug (UCB4594) is a humanized monoclonal antibody targeting human leukocyte antigen-G ( HLA-G ).
- GC79401WT1 126-134 peptide acetatePurity: >99.00%
WT1 126-134 peptide acetate is a Wilms' tumor oncogene protein ( WT1 ) peptide (RMFPNAPYL).
- GC79402Anti-pan MHC Class II (HLA II) Antibody (IVA12)Purity: >99.00%
Anti-pan MHC Class II (HLA II) Antibody (IVA12) recognizes human HLA-II (HLA-DR, HLA-DP, and HLA-DQ).
- GC79403Anti-Mouse MHC Class I (H-2Kb/H-2Db) AntibodyPurity: >98.00%
Anti-Mouse MHC Class I (H-2Kb/H-2Db) Antibody (28-8-6S) reacts with the mouse H-2Kb and H-2Db MHC Class I alloantigens.
- GC79405TSLP modulator-1Purity: >99.50%
TSLP modulator-1 (Compound 14O) is a potent TSLP signaling modulator.
- GC79407Anti-Mouse CD20 Antibody (18B12)Purity: >99.00%
Anti-Mouse CD20 Antibody (18B12) is a B cell depleting agent that targets mouse CD20.
- GC79409Pulchinenoside KCAS: 1257378-28-1Purity: >98%
Pulchinenoside K (Compound 4) is a triterpenoid saponin.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC79383 | Anti-Mouse IL-17A Antibody (BZN035) | - | >97.50% | |
Anti-Mouse IL-17A Antibody (BZN035) is an antibody targeting mouse IL-17A, which binds to and neutralizes the activity of mouse IL-17A. | ||||
| GC79384 | TSLP-IN-1 | 512837-95-5 | >99.50% | |
TSLP-IN-1 is a potent thymic stromal lymphopoietin ( TSLP ) inhibitor. | ||||
| GC79385 | Anti-Mouse IL-4Rα Antibody (REGN1103) | - | >99.50% | |
Anti-Mouse IL-4Rα Antibody (REGN1103) is a mouse homologous antibody targeting IL-4Rα, as well as an inhibitor of IL-4 signaling. | ||||
| GC79386 | Anti-Mouse IL-2 Antibody (JES6-5H4) | - | >98.50% | |
Anti-Mouse IL-2 Antibody (JES6-5H4) reacts with mouse IL-2 that can neutralize IL-2 in vivo. | ||||
| GC79389 | ETI41 | 2773474-99-8 | >98% | |
ETI41 is an orally active, selective TLR inhibitor that targets the nucleoside-binding Site I on TLR7 ( IC 50 = 0.63 μM) and TLR9 ( IC 50 = 0.16 μM), sparing surface TLRs (including TLR1/TLR2, TLR2/TLR6, TLR4 and TLR5). | ||||
| GC79390 | ETI60 | 2773475-11-7 | >99.50% | |
ETI60 is an orally active, selective TLR inhibitor that targets the nucleoside-binding Site I on TLR7 ( IC 50 = 0.68 μM) and TLR9 ( IC 50 = 0.12 μM), sparing surface TLRs (including TLR1/TLR2, TLR2/TLR6, TLR4 and TLR5). | ||||
| GC79391 | MyD88-IN-3 | - | >99.00% | |
MyD88-IN-3 is an orally active, selective MyD88 Inhibitor. | ||||
| GC79393 | PY109 | 2378039-23-5 | >99.00% | |
PY109 is an orally active and highly selective aryl hydrocarbon receptor ( AHR ) agonist. | ||||
| GC79394 | IL4RPep-1 acetate | - | >98.50% | |
IL4RPep-1 acetate is an interleukin-4 receptor ( IL-4R ) binding agent. | ||||
| GC79395 | NT-0527 | 2771019-10-2 | >99.50% | |
NT-0527 is a selective, orally active, and brain-permeable NLRP3 inflammasome inhibitor. | ||||
| GC79396 | Anti-CD3 Antibody (UCHT-1) | - | >97.00% | |
Anti-CD3 Antibody (UCHT-1) is an antibody targeting CD3. | ||||
| GC79397 | 2'2'-cGAMP disodium | - | >99.50% | |
2'2'-cGAMP disodium, a synthetic CDN, binds STING in the immune response, inducing IFN-β. 2'2'-cGAMP disodium binds weaker binding to STING than 2'3'-cGAMP but stronger than other CDNs [1] . | ||||
| GC79398 | Elfritatug | 3058391-18-4 | >98.50% | |
Elfritatug (UCB4594) is a humanized monoclonal antibody targeting human leukocyte antigen-G ( HLA-G ). | ||||
| GC79401 | WT1 126-134 peptide acetate | - | >99.00% | |
WT1 126-134 peptide acetate is a Wilms' tumor oncogene protein ( WT1 ) peptide (RMFPNAPYL). | ||||
| GC79402 | Anti-pan MHC Class II (HLA II) Antibody (IVA12) | - | >99.00% | |
Anti-pan MHC Class II (HLA II) Antibody (IVA12) recognizes human HLA-II (HLA-DR, HLA-DP, and HLA-DQ). | ||||
| GC79403 | Anti-Mouse MHC Class I (H-2Kb/H-2Db) Antibody | - | >98.00% | |
Anti-Mouse MHC Class I (H-2Kb/H-2Db) Antibody (28-8-6S) reacts with the mouse H-2Kb and H-2Db MHC Class I alloantigens. | ||||
| GC79405 | TSLP modulator-1 | - | >99.50% | |
TSLP modulator-1 (Compound 14O) is a potent TSLP signaling modulator. | ||||
| GC79406 | SMU-Z1 | 2410782-66-8 | >99.00% | |
SMU-Z1 is a TLR1/2 heterodimer agonist with an EC 50 of 4.88 nM. | ||||
| GC79407 | Anti-Mouse CD20 Antibody (18B12) | - | >99.00% | |
Anti-Mouse CD20 Antibody (18B12) is a B cell depleting agent that targets mouse CD20. | ||||
| GC79408 | NOS-IN-4 | 3737-39-1 | >97.00% | |
NOS-IN-4 (Compound 3) is a neuronal nitric oxide synthase ( nNOS ) inhibitor with an IC 50 of 4.00 μM that inhibits nNOS activity. | ||||
| GC79409 | Pulchinenoside K | 1257378-28-1 | >98% | |
Pulchinenoside K (Compound 4) is a triterpenoid saponin. | ||||
| GC79410 | (rac)-NDT-19795 | 2272918-42-8 | >99.00% | |
(rac)-NDT-19795 is the racemate of NDT-19795. | ||||
| GC79411 | TN-783 | - | >98% | |
TN-783 is an orally active, brain-penetrant NLRP3 ( IC 50 = 19.3 nM) inhibitor. | ||||
| GC79412 | IIIM-1270 | 4818-19-3 | >98.50% | |
IIIM-1270is a NLRP3 inflammasome inhibitor. | ||||
